- Home
- BNR vs MKZR Comparison
BNR vs MKZR Comparison
Compare BNR & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- MKZR
- Stock Information
- Founded
- BNR 2014
- MKZR 2012
- Country
- BNR China
- MKZR United States
- Employees
- BNR N/A
- MKZR N/A
- Industry
- BNR Medical Specialities
- MKZR
- Sector
- BNR Health Care
- MKZR
- Exchange
- BNR Nasdaq
- MKZR Nasdaq
- Market Cap
- BNR 30.9M
- MKZR 26.8M
- IPO Year
- BNR 2020
- MKZR N/A
- Fundamental
- Price
- BNR $2.84
- MKZR $1.15
- Analyst Decision
- BNR
- MKZR
- Analyst Count
- BNR 0
- MKZR 0
- Target Price
- BNR N/A
- MKZR N/A
- AVG Volume (30 Days)
- BNR 17.2K
- MKZR 33.7K
- Earning Date
- BNR 05-28-2025
- MKZR 01-01-0001
- Dividend Yield
- BNR N/A
- MKZR 17.33%
- EPS Growth
- BNR N/A
- MKZR N/A
- EPS
- BNR N/A
- MKZR N/A
- Revenue
- BNR $70,669,261.00
- MKZR $23,087,751.00
- Revenue This Year
- BNR $136.32
- MKZR N/A
- Revenue Next Year
- BNR N/A
- MKZR N/A
- P/E Ratio
- BNR N/A
- MKZR N/A
- Revenue Growth
- BNR N/A
- MKZR 57.39
- 52 Week Low
- BNR $2.62
- MKZR $1.05
- 52 Week High
- BNR $8.99
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- BNR 23.18
- MKZR N/A
- Support Level
- BNR $2.77
- MKZR N/A
- Resistance Level
- BNR $3.48
- MKZR N/A
- Average True Range (ATR)
- BNR 0.35
- MKZR 0.00
- MACD
- BNR 0.04
- MKZR 0.00
- Stochastic Oscillator
- BNR 5.93
- MKZR 0.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.